Trustedge Capital Limited has approved the grant of 8,250 stock options to eligible employees under its Trustedge Employee Stock Option Scheme 2025 (TEDGE ESOS 2025). The Nomination and Remuneration Committee passed the resolution on July 29, 2026, at 3:30 p.m., aiming to align employee interests with the company’s long-term objectives and drive future growth.

The disclosure was made in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The move is part of the company’s strategy to compensate and recognize performance while attracting and retaining talent.

Key Details of the Grant

The options are convertible into an equal number of equity shares, each with a face value of ₹10. Under the scheme, the exercise price is set at the face value, as per the provisions of the SEBI (Share Based Employee Benefits) Regulations, 2021.

Vested options may be exercised by grantees within a period of five years from the date of vesting, or such other period as determined by the Committee. The options can be exercised in full within the specified exercise window provided the grantee remains in employment with the company.

Scheme Objectives and Administration

The primary objective of TEDGE ESOS 2025 is to offer employees the opportunity to become shareholders, thereby linking their financial interests to the company’s success. The Committee will administer the scheme and determine pre-defined performance conditions for future grants. If all granted options are vested and exercised, they will result in the issuance of 8,250 additional equity shares.

Trustedge Capital Limited reported a net profit of ₹45.32 lakhs for the quarter ended June 30, 2026 (Q1FY26), reversing a loss of ₹15.93 lakhs recorded in the same period of FY25. The company’s total revenue from operations jumped 248% year-on-year to ₹271.80 lakhs, led by a sharp rise in interest income. This performance signals improved operational efficiency and higher yield generation in its core finance business.

The Board of Directors approved the unaudited financial results at a meeting held on July 29, 2026, in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, M/s Mahendra N. Shah & Co. Chartered Accountants (FRN: 105775W).

Financial Performance Highlights

Interest income, the primary revenue driver for the Non-Banking Financial Company (NBFC), rose to ₹241.47 lakhs in Q1FY26, compared to ₹55.84 lakhs in Q1FY25. Fee and commission income also increased to ₹21.47 lakhs from ₹11.50 lakhs in the prior year period. Net gain on fair value changes contributed ₹8.86 lakhs to the top line.

Total expenses stood at ₹213.80 lakhs, an increase from ₹98.75 lakhs in Q1FY25. Employee benefits expense was the largest cost component at ₹167.55 lakhs, up from ₹78.14 lakhs in the previous year. Finance costs rose to ₹29.31 lakhs from nil in the comparable period, while other expenses decreased to ₹12.69 lakhs from ₹20.56 lakhs.

What the Numbers Show

The company’s profitability recovery is heavily reliant on interest income growth, which outpaced the rise in operating expenses. While total expenses increased by approximately 116% year-on-year, revenue grew by 248%, resulting in a substantial expansion of pre-tax margins. The shift from a loss-making position to profitability indicates better asset utilization or higher lending rates, though the increase in finance costs suggests higher borrowing levels or rates may be impacting the cost of funds. Basic earnings per share (EPS) were ₹0.49, compared to a loss of ₹0.29 per share in Q1FY25.

Corporate Actions and Disclosures

During the previous fiscal year, Trustedge Capital allotted 33,74,428 fully paid-up equity shares on a rights basis at ₹80 per share, aggregating to ₹2,699.54 lakhs. The issue was made in the ratio of 49 rights equity shares for every 85 fully paid-up equity shares held as of the record date on October 1, 2025. Consequently, comparative EPS figures have been restated in accordance with Ind AS 33.

Additionally, the Nomination and Remuneration Committee approved the grant of 24,967 stock options to eligible employees under the "TEDGE ESOS 2025" scheme during its meeting on May 12, 2026. Each option is convertible into one equity share with a face value of ₹10. The diluted EPS calculation incorporates the impact of these outstanding employee stock options as per Ind AS 102.